Triopsy Edge (TE) is the only needle biopsy device capable of enhanced guidance,greater sample tissue volume with minimum patient discomfort,lower risk of complications through electrocautery,and increased reimbursement to the physician and institution. We address a $2.5B market,with 6.2% CAGR.



View Details...